[Multimodal treatment of high-risk and locally advanced prostate cancer]
{{output}}
Treatment of the high-risk and locally advanced prostate cancer is a challenge in daily practice. At 20-40%, patients with such tumor stages currently make up the majority of patients at high-volume centers. Due to COVID-19, the proportion of patients with thi... ...
